Kezar Life Sciences, Inc. (KZR) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Kezar Life Sciences, Inc. (KZR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $53.9M, listed on NASDAQ, employing roughly 55 people, carrying a beta of 0.41 to the broader market. Kezar Life Sciences, Inc. Led by Christopher J. Kirk, public since 2018-06-21.
Snapshot as of May 13, 2026.
- Spot Price
- $23.61
- ATM IV
- 251.9%
- IV Skew 25Δ
- 0.083
- IV Rank
- 49.7%
- IV Percentile
- 82.1%
- Term Structure Slope
- -2.099
As of May 13, 2026, Kezar Life Sciences, Inc. (KZR) at-the-money implied volatility is 251.9%. IV rank is 49.7% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 82.1%. The 25-delta skew is +0.083: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
KZR Strategy Selection at Current Volatility Levels
For Kezar Life Sciences, Inc. options at 251.9% ATM IV, mid-range IV rank (49.7%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked KZR volatility skew questions
- What is the current KZR ATM implied volatility?
- As of May 13, 2026, Kezar Life Sciences, Inc. (KZR) at-the-money implied volatility is 251.9%. IV rank is 49.7% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is KZR IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does KZR volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Kezar Life Sciences, Inc. shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.